Navigation Links
China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results
Date:9/1/2009

BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the first fiscal quarter ended June 30, 2009 ("1Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009").

    1Q FY2009 Highlights

    -- Revenues from continuing operations increased by 28.9% year-over-year
       to RMB209.0 million (US$30.6 million).
    -- Income from continuing operations decreased by 92.8% year-over-year to
       RMB2.9 million (US$0.4 million).
    -- Net income decreased by 96.0% year-over-year to RMB2.9 million (US$0.4
       million).
    -- Non-GAAP income from continuing operations, as defined below, decreased
       by 7.7% year-over-year to RMB72.5 million (US$10.6 million).
    -- Diluted earnings from continuing operations per ADS* was RMB0.11
       (US$0.02).
    -- Non-GAAP diluted earnings from continuing operations per ADS*, as
       defined below, decreased by 7.7% year-over-year to RMB2.74 (US$0.40).

    *One American Depositary Share ("ADS") = 10 ordinary shares

See "Non-GAAP Measure Disclosures" below, where the impact of certain items on reported results is discussed.

"While we remain confident in the fundamentals of the Company and its prospects in the longer term, we were recently affected on several fronts," commented Mr. Xiaodong Wu, Chairman and Chief Executive Officer of the Company. "Our ECLIA customers, mainly distributors, have reduced their inventory level during the past months in anticipation of a price reduction on our ECLIA reagent kits due to increasing market competition. We have reduced the s
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results
2. China Medicine Enhances Management Team with Appointments of New Chief Financial Officer and Finance Manager
3. China Sky One Medical, Inc. to Hold Annual Meeting of Shareholders on September 24, 2009
4. Linkwell Corporation Announces Launch of the Establishment of 100 Model Hospitals Across China
5. Linkwell Corporation Announces Launch of the Series of Handwashing Contest Across China
6. China Healthcare Corp. Provides Update on JV to Build its First Hospital in China
7. China Kangtai Cactus Biotech to Attend Rodman & Renshaw Conference and Meet with Investors in September
8. China Nepstar Chain Drugstore Announces Special Dividend
9. China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results
10. China Nepstar Chain Drugstore Announces Management Change
11. China Shenghuo Reports Unaudited Financial Results for the Second Quarter of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Early surgery may not be the ... joint injuries, according to new research from Tripler Army ... Orthopaedic Society for Sports Medicine’s ( AOSSM ) Specialty ... surgery was not performed. , The final study group ... and 17 receiving non-surgical therapy. Of the non-surgery group, ...
(Date:3/28/2015)... Lately the student-athlete experience has ... proposals around the NCAA. In a March episode of ... across a spectrum of universities and sports shed light ... special panel consists of athletes who have competed for ... track and field, baseball, and volleyball. They discuss the ...
(Date:3/28/2015)... 28, 2015 The "Petrick Sustainable ... sustainable health. After 18 years of research and experience ... UFC contenders, Dr. Jon Petrick is excited to be ... some of the immediate benefits of this radical new ... levels of strength of the immune system, faster healing ...
(Date:3/28/2015)... Plainview, NY (PRWEB) March 28, 2015 ... provider of dietary supplements announces the release of ... MuffinStop™ was shown in two randomized, double-blind, placebo-controlled ... weight and waist and hip size. MuffinStop™ is ... Sphaeranthus indicus and Garcinia mangostana, fused together to ...
(Date:3/27/2015)... FL (PRWEB) March 27, 2015 The ... guide from dating experts Samantha Sanderson and Jason Rogers ... frenzied buzz of media attention. The commotion surrounding the ... Roman, prompting him to publish an in-depth review of ... devastated when the men in their lives suddenly start ...
Breaking Medicine News(10 mins):Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2
... Treuman Katz Center for Pediatric Bioethics at Seattle Children,s ... Conference on Friday, July 22 and Saturday, July 23. ... policy boundaries and complexities of providing healthcare to children. ... the Boundaries of Clinical Ethics and Public Policy," will ...
... HealthDay Reporter , WEDNESDAY, July 20 (HealthDay ... skin rashes, but the similarities between the two common, ... examining patients suffering from both ailments (a very rare ... system responses that prompt skin flare-ups for both diseases. ...
... , WEDNESDAY, July 20 (HealthDay News) -- The ... their patients, health, new research indicates. It also plays ... errors and patient satisfaction, according to a commentary in the ... who are civil, the report claimed, can more effectively help ...
... HealthDay Reporter , WEDNESDAY, July 20 (HealthDay News) ... be heating up. New technology promises to cut costs while ... of your genes and potentially provide a personalized report of ... The human genome was first mapped in 2001 and cost ...
... cascade of chemistry to stem the flow of blood. Now, ... have used evolutionary clues to reveal how a key clotting ... disorders. The long tube-shaped protein with a vital role ... in cells that form the inner lining of blood vessels, ...
... , In the fight to improve global health, alleviate ... developing world, chickens have an important role to play. ... Center for Infectious Diseases and Vaccinology at Arizona State ... a more productive species of chicken for villagers in ...
Cached Medicine News:Health News:Exploring the limits of children's health care: What's the reality of providing care to all? 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 2Health News:Scientists Close in on Origins of Psoriasis, Eczema 3Health News:Rude Surgeons Hurt Patients, Increase Costs 2Health News:Cheaper DNA Sequencing Coming Closer 2Health News:Cheaper DNA Sequencing Coming Closer 3Health News:Evolution provides clue to blood clotting 2Health News:Evolution provides clue to blood clotting 3Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 2Health News:A new breed: Highly productive chickens help raise Ugandans from poverty 3
(Date:3/27/2015)... LAVAL, Quebec , March 27, 2015  Valeant ... announced today the closing of its previously announced registered ... States (the "Offering"). Pursuant to the Offering, ... of $199.00 per share, for aggregate gross proceeds of ... filed with the U.S. Securities and Exchange Commission a ...
(Date:3/27/2015)... , March 27, 2015   Hospira, ... leader in biosimilars and the world,s leading provider ... studies that support an evaluation of biosimilarity of ... Food and Drug Administration (FDA) conditionally approved name ... EPOGEN™ (epoetin alfa). These study data were presented ...
(Date:3/27/2015)...  Delcath Systems, Inc. (NASDAQ: DCTH ), ... on oncology with an emphasis on the treatment ... reporting of data from a single -center experience ... the Delcath Hepatic Delivery System (Melphalan/HDS) and other ... of Surgical Oncology (SSO) Annual Meeting 2015.  The ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: